title: [Case-control study on spinal leveraging manipulation and medicine for the treatment of degenerative scoliosis].
abstract: OBJECTIVE
  To compare clinical effects of spinal leveraging manipulation and medicine for the treatment of degenerative scoliosis in pain and function.
  
  
  METHODS
  From July 2010 to June 2013, 38 patients with degenerative scoliosis were randomly divided into spinal leveraging manipulation group and medicine group by coin tossing. In manipulation group, there were 9 males and 11 females aged from 58 to 74 years old with an average of (66.63±7.73), the courses of diseases ranged from 3 to 8 months with an average of (5.65±2.58), spinal leveraging manipulation(following meridian to straighten tendon,relieving spasm, osteopathy and massage, clearing and activating the channels and collaterals) were performed for 30 min, once a day, 4 days for a period treatment, totally 9 courses. In medicine group, there were 8 males and 10 females aged from 57 to 70 years old with an average of (63.51±6.61) the courses of diseases ranged from 3 to 5 months with an average of (4.82±1.43), celecoxib with eperisone hydrochloride were orally taken, 4 days for a period treatment, totally 9 courses. VAS score, Cobb angle and ODI score were measured.
  
  
  RESULTS
  After treatment, VAS score in manipulation group was (5.38±0.99), (6.36±1.31) in medicine group,and had significant meaning (t=2.618, P<0.05); there was significant differences in Cobb angle between manipulation group (16.51±4.89)° and medicine group (19.85±5.03) °(t=2.074,P<0.05); and had obviously meaning in ODI score between manipulation group (20.20±2.93) and medicine group (26.01±3.11) (t=5.592, P<0.05).
  
  
  CONCLUSIONS
  Spinal leveraging manipulation for degenerative scoliosis could regulate muscle balance on both side of spine, correct coronal imbalances in spine, recover normal sequence of spine, reduce and remove opperssion and stimulation of nerve root, relieve pain in leg and waist and further improve quality of life.
authors.forename: Gang
authors.initials: G
authors.lastname: Tian
authors.forename: Mao-rong
authors.initials: MR
authors.lastname: Shen
authors.forename: Wei-guo
authors.initials: WG
authors.lastname: Jiang
authors.forename: Fu-rong
authors.initials: FR
authors.lastname: Xie
authors.forename: Wen-wu
authors.initials: WW
authors.lastname: Wei
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D000068579:Celecoxib; D005260:Female; D006801:Humans; D008159:Lumbar Vertebrae / Q000601:surgery; D008297:Male; D020393:Manipulation, Spinal; D008875:Middle Aged; D011427:Propiophenones / Q000008:administration & dosage*; D011720:Pyrazoles / Q000008:administration & dosage*; D012600:Scoliosis / Q000188:drug therapy / Q000628:therapy*; D013449:Sulfonamides / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D011427:Propiophenones; D011720:Pyrazoles; D013449:Sulfonamides; C030848:eperisone; D000068579:Celecoxib